SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-20-018010
Filing Date
2020-10-20
Accepted
2020-10-20 16:59:25
Documents
1
Period of Report
2020-10-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 31299
  Complete submission text file 0001567619-20-018010.txt   33857
Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0818
Vivo Capital Fund VIII, L.P. (Reporting) CIK: 0001618788 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39617 | Film No.: 201248807

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Reporting) CIK: 0001618789 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39617 | Film No.: 201248806

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0818
Vivo Capital Surplus Fund VIII, L.P. (Reporting) CIK: 0001628048 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39617 | Film No.: 201248808

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Issuer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)